Type I Interferons, Autophagy and Host Metabolism in Leprosy

For those with leprosy, the extent of host infection by Mycobacterium leprae and the progression of the disease depend on the ability of mycobacteria to shape a safe environment for its replication during early interaction with host cells. Thus, variations in key genes such as those in pattern recog...

Full description

Bibliographic Details
Main Authors: Thiago Gomes Toledo Pinto, Leonardo Ribeiro Batista-Silva, Rychelle Clayde Affonso Medeiros, Flávio Alves Lara, Milton Ozório Moraes
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-04-01
Series:Frontiers in Immunology
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fimmu.2018.00806/full
_version_ 1811263661036011520
author Thiago Gomes Toledo Pinto
Leonardo Ribeiro Batista-Silva
Rychelle Clayde Affonso Medeiros
Flávio Alves Lara
Milton Ozório Moraes
author_facet Thiago Gomes Toledo Pinto
Leonardo Ribeiro Batista-Silva
Rychelle Clayde Affonso Medeiros
Flávio Alves Lara
Milton Ozório Moraes
author_sort Thiago Gomes Toledo Pinto
collection DOAJ
description For those with leprosy, the extent of host infection by Mycobacterium leprae and the progression of the disease depend on the ability of mycobacteria to shape a safe environment for its replication during early interaction with host cells. Thus, variations in key genes such as those in pattern recognition receptors (NOD2 and TLR1), autophagic flux (PARK2, LRRK2, and RIPK2), effector immune cytokines (TNF and IL12), and environmental factors, such as nutrition, have been described as critical determinants for infection and disease progression. While parkin-mediated autophagy is observed as being essential for mycobacterial clearance, leprosy patients present a prominent activation of the type I IFN pathway and its downstream genes, including OASL, CCL2, and IL10. Activation of this host response is related to a permissive phenotype through the suppression of IFN-γ response and negative regulation of autophagy. Finally, modulation of host metabolism was observed during mycobacterial infection. Both changes in lipid and glucose homeostasis contribute to the persistence of mycobacteria in the host. M. leprae-infected cells have an increased glucose uptake, nicotinamide adenine dinucleotide phosphate generation by pentose phosphate pathways, and downregulation of mitochondrial activity. In this review, we discussed new pathways involved in the early mycobacteria–host interaction that regulate innate immune pathways or metabolism and could be new targets to host therapy strategies.
first_indexed 2024-04-12T19:49:21Z
format Article
id doaj.art-fc7009f2b13e4ccdb770726af0b8acff
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-12T19:49:21Z
publishDate 2018-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-fc7009f2b13e4ccdb770726af0b8acff2022-12-22T03:18:53ZengFrontiers Media S.A.Frontiers in Immunology1664-32242018-04-01910.3389/fimmu.2018.00806340943Type I Interferons, Autophagy and Host Metabolism in LeprosyThiago Gomes Toledo Pinto0Leonardo Ribeiro Batista-Silva1Rychelle Clayde Affonso Medeiros2Flávio Alves Lara3Milton Ozório Moraes4Leprosy Laboratory, Oswaldo Cruz Institute, Rio de Janeiro, BrazilLeprosy Laboratory, Oswaldo Cruz Institute, Rio de Janeiro, BrazilLeprosy Laboratory, Oswaldo Cruz Institute, Rio de Janeiro, BrazilLaboratory of Cellular Microbiology, Oswaldo Cruz Institute, Rio de Janeiro, BrazilLeprosy Laboratory, Oswaldo Cruz Institute, Rio de Janeiro, BrazilFor those with leprosy, the extent of host infection by Mycobacterium leprae and the progression of the disease depend on the ability of mycobacteria to shape a safe environment for its replication during early interaction with host cells. Thus, variations in key genes such as those in pattern recognition receptors (NOD2 and TLR1), autophagic flux (PARK2, LRRK2, and RIPK2), effector immune cytokines (TNF and IL12), and environmental factors, such as nutrition, have been described as critical determinants for infection and disease progression. While parkin-mediated autophagy is observed as being essential for mycobacterial clearance, leprosy patients present a prominent activation of the type I IFN pathway and its downstream genes, including OASL, CCL2, and IL10. Activation of this host response is related to a permissive phenotype through the suppression of IFN-γ response and negative regulation of autophagy. Finally, modulation of host metabolism was observed during mycobacterial infection. Both changes in lipid and glucose homeostasis contribute to the persistence of mycobacteria in the host. M. leprae-infected cells have an increased glucose uptake, nicotinamide adenine dinucleotide phosphate generation by pentose phosphate pathways, and downregulation of mitochondrial activity. In this review, we discussed new pathways involved in the early mycobacteria–host interaction that regulate innate immune pathways or metabolism and could be new targets to host therapy strategies.http://journal.frontiersin.org/article/10.3389/fimmu.2018.00806/fullleprosytuberculosisinnate immunityautophagytype I interferonmetabolism
spellingShingle Thiago Gomes Toledo Pinto
Leonardo Ribeiro Batista-Silva
Rychelle Clayde Affonso Medeiros
Flávio Alves Lara
Milton Ozório Moraes
Type I Interferons, Autophagy and Host Metabolism in Leprosy
Frontiers in Immunology
leprosy
tuberculosis
innate immunity
autophagy
type I interferon
metabolism
title Type I Interferons, Autophagy and Host Metabolism in Leprosy
title_full Type I Interferons, Autophagy and Host Metabolism in Leprosy
title_fullStr Type I Interferons, Autophagy and Host Metabolism in Leprosy
title_full_unstemmed Type I Interferons, Autophagy and Host Metabolism in Leprosy
title_short Type I Interferons, Autophagy and Host Metabolism in Leprosy
title_sort type i interferons autophagy and host metabolism in leprosy
topic leprosy
tuberculosis
innate immunity
autophagy
type I interferon
metabolism
url http://journal.frontiersin.org/article/10.3389/fimmu.2018.00806/full
work_keys_str_mv AT thiagogomestoledopinto typeiinterferonsautophagyandhostmetabolisminleprosy
AT leonardoribeirobatistasilva typeiinterferonsautophagyandhostmetabolisminleprosy
AT rychelleclaydeaffonsomedeiros typeiinterferonsautophagyandhostmetabolisminleprosy
AT flavioalveslara typeiinterferonsautophagyandhostmetabolisminleprosy
AT miltonozoriomoraes typeiinterferonsautophagyandhostmetabolisminleprosy